Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.33 |
| ▸ | PYGL | P06737 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20026745 | 1.00 | F2 (0.33) | F2PYGL | |
| SCHEMBL21878969 | 1.00 | F2 (0.33) | F2PYGL | |
| SCHEMBL17492914 | 1.00 | F2 (0.33) | F2PYGL | |
| SCHEMBL17492915 | 1.00 | F2 (0.33) | F2PYGL | |
| SCHEMBL17492937 | 0.96 | F2 (0.34) | F2 | |
| SCHEMBL17492938 | 0.96 | F2 (0.34) | F2 | |
| SCHEMBL22167188 | 0.95 | F2 (0.31) | F2PYGL | |
| SCHEMBL17492907 | 0.95 | F2 (0.31) | F2PYGL | |
| SCHEMBL17459563 | 0.95 | F2 (0.31) | F2PYGL | |
| SCHEMBL22167410 | 0.95 | ITGB1 (0.33) | F2PYGL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3519407-B1 | DIMETHYLAMINOETHANOL SALT OF A GLP-1 RECEPTOR MODULATOR | RECEPTOS LLC (US) | 2021-09-22 | — | — | EP | disclosed |
| US-11066395-B2 | Dimethylaminoethanol salt of a GLP-1 receptor modulator | RECEPTOS LLC (US) | 2021-07-20 | — | — | US | disclosed |
| US-20200131164-A1 | DIMETHYLAMINOETHANOL SALT OF A GLP-1 RECEPTOR MODULATOR | RECEPTOS LLC | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131164-A1 | DIMETHYLAMINOETHANOL SALT OF A GLP-1 RECEPTOR MODULATOR | GLP1R, GIPR, GPR119 | F2 4749/4885PYGL 1787/4885 |
| US-11066395-B2 | Dimethylaminoethanol salt of a GLP-1 receptor modulator | GLP1R, GIPR, GPR119 | F2 4749/4885PYGL 1787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.